These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 214218)

  • 21. Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects.
    Chlebowski RT; Chan KK; Tong MJ; Weiner JM; Ryden VM; Bateman JR
    Cancer; 1981 Sep; 48(5):1088-95. PubMed ID: 6268277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study in man of recirculation and tissue uptake of 5-FU 6 H3].
    Bessot M; Duprez A; Mauuary G; Winsback AM
    Biol Gastroenterol (Paris); 1971; 1():71-7. PubMed ID: 4327245
    [No Abstract]   [Full Text] [Related]  

  • 23. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
    Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
    N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results with methyl-CCNU and DTIC in metastatic melanoma.
    Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
    Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
    Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
    Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
    Kolarić K; Potrebica V; Stanovnik M
    Oncology; 1986; 43(2):73-7. PubMed ID: 3513075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
    J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
    Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
    J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
    Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
    J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.
    Song MJ; Bae SH; Chun HJ; Choi JY; Yoon SK; Park JY; Han KH; Kim YS; Yim HJ; Um SH; Chung WJ; Hwang JS; Cho SB; Eun JR
    Cancer Chemother Pharmacol; 2015 Apr; 75(4):739-46. PubMed ID: 25663125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma.
    Weltz MD; Perry DJ; Blom J; Butler WM
    J Clin Oncol; 1983 Feb; 1(2):135-7. PubMed ID: 6230421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chemotherapy of gastrointestinal cancer (author's transl)].
    Gropp C; Havemann K
    Z Gastroenterol; 1978 Oct; 16(10):609-15. PubMed ID: 151993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
    Witte RS; Cnaan A; Mansour EG; Barylak E; Harris JE; Schutt AJ
    Cancer; 2001 Mar; 91(5):1020-8. PubMed ID: 11251955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II-III chemotherapy studies in advanced gastric cancer. The Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1979; 63(11-12):1871-6. PubMed ID: 393382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma.
    Doci R; Bignami P; Bozzetti F; Bonfanti G; Audisio R; Colombo M; Gennari L
    Cancer; 1988 May; 61(10):1983-7. PubMed ID: 2834036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.